HY209gel

· Shaperon

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HY209gel, covering 2026-02-23 to 2026-02-23. Get the full timeline:

Most recent: Clinical Trial Update: Phase 2 Trial of HY209gel in Atopic Dermatitis Patients [Phase 2]